Revenue
$20.38B
Fiscal year ended 2025-12-31Operating income
$3.31B
Fiscal year ended 2025-12-31Free cash flow
Unavailable
Fiscal year ended 2025-12-31COLGATE PALMOLIVE CO (CL) reported revenue of $20.38B and net income of $2.13B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from COLGATE PALMOLIVE CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Perfumes, Cosmetics & Other Toilet Preparations.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B | $16.47B | $15.69B | $15.54B | $15.45B | $15.20B |
| Cost of revenue | $8.13B | $7.94B | $8.13B | $7.72B | $7.05B | $6.45B | $6.37B | $6.31B | $6.17B | $6.07B |
| Gross profit | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B | $10.02B | $9.32B | $9.23B | $9.28B | $9.12B |
| Operating income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B | $3.88B | $3.55B | $3.69B | $3.71B | $3.96B |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B | $2.70B | $2.37B | $2.40B | $2.02B | $2.44B |
| Research & development | $366.00M | $355.00M | $343.00M | $320.00M | $307.00M | $290.00M | $281.00M | $277.00M | $285.00M | $289.00M |
| Weighted-average diluted shares | shares 811.10M | shares 823.20M | shares 829.20M | shares 838.80M | shares 848.30M | shares 859.30M | shares 861.10M | shares 873.00M | shares 887.80M | shares 898.40M |
| Pretax income | $3.06B | $3.96B | $3.39B | $2.66B | $3.09B | $3.65B | $3.30B | $3.46B | $3.49B | $3.74B |
| Income tax expense | $798.00M | $907.00M | $937.00M | $693.00M | $749.00M | $787.00M | $774.00M | $906.00M | $1.31B | $1.15B |
| Diluted EPS | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 |
| Selling, general & administrative | $7.90B | $7.73B | $7.15B | $6.56B | $6.41B | $6.02B | $5.58B | $5.39B | $5.40B | $5.14B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.29B | $1.10B | $966.00M | $775.00M | $832.00M | $888.00M | $883.00M | $726.00M | $1.54B | $1.32B |
| Total assets | $16.33B | $16.05B | $16.39B | $15.73B | $15.04B | $15.92B | $15.03B | $12.16B | $12.68B | $12.12B |
| Current assets | $5.71B | $5.32B | $5.28B | $5.11B | $4.40B | $4.34B | $4.18B | $3.79B | $4.64B | $4.34B |
| Total liabilities | $15.96B | $15.50B | $15.44B | $14.92B | $14.07B | $14.82B | $14.48B | $11.96B | $12.43B | $12.11B |
| Current liabilities | $6.85B | $5.76B | $4.74B | $4.00B | $4.05B | $4.40B | $4.04B | $3.34B | $3.41B | $3.30B |
| Total equity incl. NCI | $365.00M | $544.00M | $957.00M | $806.00M | $971.00M | $1.10B | $558.00M | $197.00M | $243.00M | $17.00M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $2.03B | $1.99B | $1.93B | $2.07B | $1.69B | $1.67B | $1.40B | $1.25B | $1.22B | $1.17B |
| Accounts receivable | $1.68B | $1.52B | $1.59B | $1.50B | $1.30B | $1.26B | $1.44B | $1.40B | $1.48B | $1.41B |
| Goodwill | $3.12B | $3.27B | $3.41B | $3.35B | $3.28B | $3.82B | $3.51B | $2.53B | $2.22B | $2.11B |
| Long-term debt | $6.87B | $7.29B | $8.22B | $8.74B | $7.19B | $7.33B | $7.33B | $6.35B | $6.57B | $6.52B |
| Accounts payable | $2.09B | $1.80B | $1.70B | $1.55B | $1.48B | $1.39B | $1.24B | $1.22B | $1.21B | $1.12B |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.20B | $4.11B | $3.74B | $2.56B | $3.32B | $3.72B | $3.13B | $3.06B | $3.05B | $3.14B |
| Capital expenditures | Unavailable | Unavailable | Unavailable | $696.00M | $567.00M | $409.00M | $335.00M | $436.00M | $553.00M | $593.00M |
| Investing cash flow | -$817.00M | -$534.00M | -$742.00M | -$1.60B | -$592.00M | -$779.00M | -$2.10B | -$1.17B | -$471.00M | -$499.00M |
| Financing cash flow | -$3.26B | -$3.39B | -$2.79B | -$952.00M | -$2.77B | -$2.92B | -$870.00M | -$2.68B | -$2.45B | -$2.23B |
| Net change in cash | $192.00M | $130.00M | $191.00M | -$57.00M | -$56.00M | $5.00M | $157.00M | -$809.00M | $220.00M | $345.00M |
| Stock-based compensation | $155.00M | $135.00M | $122.00M | $125.00M | $135.00M | $107.00M | $100.00M | $109.00M | $127.00M | $123.00M |
| Common dividends paid | $1.82B | $1.79B | $1.75B | $1.69B | $1.68B | $1.65B | $1.61B | $1.59B | $1.53B | $1.51B |
| Common share repurchases | $1.21B | $1.74B | $1.13B | $1.31B | $1.32B | $1.48B | $1.20B | $1.24B | $1.40B | $1.34B |
| Depreciation & amortization | $630.00M | $605.00M | $567.00M | $545.00M | $556.00M | $539.00M | $519.00M | $511.00M | $475.00M | $443.00M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $3.31B | $2.80B | $2.62B | $2.50B | $2.55B |
| Gross margin | 60.1% | 60.5% | 58.2% | 57.0% | 59.6% | 60.8% | 59.4% | 59.4% | 60.0% | 60.0% |
| Operating margin | 16.2% | 21.2% | 20.5% | 16.1% | 19.1% | 23.6% | 22.6% | 23.8% | 24.0% | 26.0% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 20.1% | 17.8% | 16.9% | 16.2% | 16.8% |
| SBC / revenue | 0.8% | 0.7% | 0.6% | 0.7% | 0.8% | 0.6% | 0.6% | 0.7% | 0.8% | 0.8% |
| Current ratio | 0.83x | 0.92x | 1.11x | 1.28x | 1.09x | 0.99x | 1.03x | 1.14x | 1.36x | 1.31x |
| Revenue YoY growth | 1.4% | 3.3% | 8.3% | 3.1% | 5.8% | 5.0% | 1.0% | 0.6% | 1.7% | Unavailable |
| Net margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% |
| R&D / revenue | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.9% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 2.5% | 2.1% | 2.8% | 3.6% | 3.9% |
| Long-term debt / equity | 18.82x | 13.40x | 8.59x | 10.84x | 7.41x | 6.66x | 13.14x | 32.25x | 27.02x | 383.53x |
| Effective tax rate | 26.1% | 22.9% | 27.6% | 26.1% | 24.3% | 21.6% | 23.4% | 26.2% | 37.7% | 30.8% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CL in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-31View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-02-23View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-01View SEC filing
10-Q · Filed 2025-04-25View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.